118 related articles for article (PubMed ID: 35529902)
1. MAPK signaling regulates the efficacy of chemoimmunotherapy.
Ghiringhelli F
Mol Cell Oncol; 2022; 9(1):2054652. PubMed ID: 35529902
[TBL] [Abstract][Full Text] [Related]
2. MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells.
Limagne E; Nuttin L; Thibaudin M; Jacquin E; Aucagne R; Bon M; Revy S; Barnestein R; Ballot E; Truntzer C; Derangère V; Fumet JD; Latour C; Rébé C; Bellaye PS; Kaderbhaï CG; Spill A; Collin B; Callanan MB; Lagrange A; Favier L; Coudert B; Arnould L; Ladoire S; Routy B; Joubert P; Ghiringhelli F
Cancer Cell; 2022 Feb; 40(2):136-152.e12. PubMed ID: 35051357
[TBL] [Abstract][Full Text] [Related]
3. Mitophagy: a new actor in the efficacy of chemo-immunotherapy.
Limagne E; Ghiringhelli F
Autophagy; 2022 Dec; 18(12):3033-3034. PubMed ID: 35532360
[TBL] [Abstract][Full Text] [Related]
4. MEK inhibition invigorates chemoimmunotherapy by tumor mitophagy-induced CXCL10 expression.
Rodriguez BL; Gibbons DL
Cell Rep Med; 2022 Jan; 3(1):100506. PubMed ID: 35106515
[TBL] [Abstract][Full Text] [Related]
5. The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage.
Thobe BM; Frink M; Hildebrand F; Schwacha MG; Hubbard WJ; Choudhry MA; Chaudry IH
J Cell Physiol; 2007 Mar; 210(3):667-75. PubMed ID: 17117477
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.
Dai Y; Yu C; Singh V; Tang L; Wang Z; McInistry R; Dent P; Grant S
Cancer Res; 2001 Jul; 61(13):5106-15. PubMed ID: 11431348
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 9 signaling promotes autophagy and apoptosis via divergent functions of the p38/JNK pathway in human salivary gland cells.
Fu J; Shi H; Cao N; Wu S; Zhan T; Xie L; Wang Z; Ye L; Li C; Shen Y; Yu C; Zheng L
Exp Cell Res; 2019 Feb; 375(2):51-59. PubMed ID: 30610847
[TBL] [Abstract][Full Text] [Related]
8. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
[TBL] [Abstract][Full Text] [Related]
9. Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer.
Kitai H; Ebi H
Small GTPases; 2017 Jul; 8(3):172-176. PubMed ID: 27392325
[TBL] [Abstract][Full Text] [Related]
10. Collaborative action of NF-kappaB and p38 MAPK is involved in CpG DNA-induced IFN-alpha and chemokine production in human plasmacytoid dendritic cells.
Osawa Y; Iho S; Takauji R; Takatsuka H; Yamamoto S; Takahashi T; Horiguchi S; Urasaki Y; Matsuki T; Fujieda S
J Immunol; 2006 Oct; 177(7):4841-52. PubMed ID: 16982926
[TBL] [Abstract][Full Text] [Related]
11. Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy.
Baumann D; Offringa R
Cell Stress; 2020 Aug; 4(10):248-251. PubMed ID: 33024933
[TBL] [Abstract][Full Text] [Related]
12. Cigarette smoke exposure reveals a novel role for the MEK/ERK1/2 MAPK pathway in regulation of CFTR.
Xu X; Balsiger R; Tyrrell J; Boyaka PN; Tarran R; Cormet-Boyaka E
Biochim Biophys Acta; 2015 Jun; 1850(6):1224-32. PubMed ID: 25697727
[TBL] [Abstract][Full Text] [Related]
13. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway.
Yu C; Wang S; Dent P; Grant S
Mol Pharmacol; 2001 Jul; 60(1):143-54. PubMed ID: 11408609
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein bad.
Eisenmann KM; VanBrocklin MW; Staffend NA; Kitchen SM; Koo HM
Cancer Res; 2003 Dec; 63(23):8330-7. PubMed ID: 14678993
[TBL] [Abstract][Full Text] [Related]
15. Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer.
Liu S; Zou Q; Chen JP; Yao X; Guan P; Liang W; Deng P; Lai X; Yin J; Chen J; Chen R; Yu Z; Xiao R; Sun Y; Hong JH; Liu H; Lu H; Chen J; Bei JX; Koh J; Chan JY; Wang B; Kang T; Yu Q; Teh BT; Liu J; Xiong Y; Tan J
J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34464356
[TBL] [Abstract][Full Text] [Related]
16. Exogenous administration of mitochondrial DNA promotes ischemia reperfusion injury via TLR9-p38 MAPK pathway.
Xie L; Liu S; Cheng J; Wang L; Liu J; Gong J
Regul Toxicol Pharmacol; 2017 Oct; 89():148-154. PubMed ID: 28757323
[TBL] [Abstract][Full Text] [Related]
17. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery.
Okano J ; Rustgi AK
J Biol Chem; 2001 Jun; 276(22):19555-64. PubMed ID: 11278851
[TBL] [Abstract][Full Text] [Related]
19. Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma.
He X; Du Y; Wang Z; Wang X; Duan J; Wan R; Xu J; Zhang P; Wang D; Tian Y; Han J; Fei K; Bai H; Tian J; Wang J
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115941
[TBL] [Abstract][Full Text] [Related]
20. Grancalcin (GCA) modulates Toll-like receptor 9 (TLR9) mediated signaling through its direct interaction with TLR9.
Kim TW; Hong S; Talukder AH; Pascual V; Liu YJ
Eur J Immunol; 2016 Mar; 46(3):712-24. PubMed ID: 26648480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
